• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    7.81 Down 0.05(0.64%) Jan 30, 4:00PM EST
    |After Hours : 8.00 Up 0.19 (2.43%) Jan 30, 7:49PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 8,214   8,259   7,462   8,748  
    Cost of Revenue4,027  5,102  3,021  2,603  
    Gross Profit 4,187   3,157   4,441   6,145  
    Operating Expenses
    Research Development19,220  15,202  14,518  16,319  
    Selling General and Administrative4,757  5,806  4,308  4,079  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (19,790) (17,851) (14,385) (14,253)
    Income from Continuing Operations
    Total Other Income/Expenses Net110  38  627  230  
    Earnings Before Interest And Taxes(19,680)(17,813)(13,758)(14,023)
    Interest Expense47  51  52  28  
    Income Before Tax(19,727)(17,864)(13,810)(14,051)
    Income Tax Expense -   -   -  3  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(19,727)(17,864)(13,810)(14,054)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (19,727) (17,864) (13,810) (14,054)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (19,727) (17,864) (13,810) (14,054)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.